Vertex Pharmaceuticals (United States)

1.4k papers and 84.4k indexed citations i.

About

In recent decades, authors affiliated with Vertex Pharmaceuticals (United States) have published 1.4k papers, which have received a total of 84.4k indexed citations. Scholars at this organization have produced 518 papers in Molecular Biology, 178 papers in Pulmonary and Respiratory Medicine and 154 papers in Oncology on the topics of Therapeutic Advances in Cystic Fibrosis Research (149 papers), Hepatitis C virus research (135 papers) and Computational Drug Discovery Methods (106 papers). Their work is cited by papers focused on Molecular Biology (39.7k citations), Epidemiology (12.8k citations) and Pulmonary and Respiratory Medicine (11.1k citations). Authors at Vertex Pharmaceuticals (United States) collaborate with scholars in United States, United Kingdom and Germany and have published in prestigious journals including Nature, Science and Cell. Some of Vertex Pharmaceuticals (United States)'s most productive authors include Keisuke Kuida, Mark A. Murcko, Michael Su, David J. Livingston and Ann D. Kwong

In The Last Decade

Rankless by CCL
2025